Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > SAVA Cassava Sciences > Detailed Quotes

SAVA Cassava Sciences

Watchlist
42.674
-0.396-0.92%
Trading Session 09/30 12:58 ET
Giving away premium quotes worth 5000 HKD/year to unlock more data
Get NOW
High
44.800
Open
42.630
Turnover
43.18M
Low
42.510
Pre Close
43.070
Volume
991.27K
Market Cap
1.71B
P/E(TTM)
Loss
52wk High
100.000
Shares
40.10M
P/E(Static)
Loss
52wk Low
13.840
Float Cap
1.56B
Bid/Ask %
0.00%
Historical High
146.160
Shs Float
36.51M
Volume Ratio
0.27
Historical Low
1.000
Dividend TTM
--
Div Yield TTM
--
P/B
7.84
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
2.71%
Amplitude
5.32%
Avg Price
43.556
Lot Size
1
Float Cap
1.56B
Bid/Ask %
0.00%
Historical High
146.160
Shs Float
36.51M
Volume Ratio
0.27
Historical Low
1.000
Dividend TTM
--
P/B
7.84
Dividend LFY
--
Turnover Ratio
2.71%
Amplitude
5.32%
Avg Price
43.556
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.
CEO: Barbier, Remi
Market: NASDAQ
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top